Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. Chris explains how the Inflation Reduction Act of 2022 (IRA) will impact hub, patient assistance ...
April is over, so it's time to hop into this month’s selection of noteworthy news: CVS Health’s formulary boosts a Humira biosimilar An insurer ditches buy-and-bill to save money for plans�...
Today’s guest post comes from Kevin Kettler, President of CoverMyMeds. Kevin asks: What if there were no barriers across the therapy access and reimbursement process? In his view, eliminatin...
Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, He...
Next week, the Drug Channels Institute team will be attending Asembia’s AXS24 Summit at the wonderful Wynn Las Vegas. And for the first time—thanks to our new friends at HMP Global —DCI ...
Today’s guest post comes from Jim Sheninger, Pharmacy Strategy Officer at GoodRx. Jim describes GoodRx's emerging pharmacy contracting strategies. In addition to working through pharmacy ben...
Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialty pharmacy market continue to get more diverse—although revenues remain highly concentrated. We h...
Today’s guest post comes from Jessica Lens, Chief Patient Experience Officer at CareMetx. Jessica discusses the challenges of patient nonadherence. She then outlines how manufacturers can bu...
Three is still the magic number for pharmacy benefit managers (PBMs). For 2023, nearly 80% of all equivalent prescription claims were processed by three companies: the Caremark business of CVS...
I am pleased to announce the inaugural DRUG CHANNELS LEADERSHIP FORUM ! This unique, new event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. The Leadership ...
This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: DRUG CHANNEL IMPLICATIONS OF THE INFLATION REDUCTION ACT . One important update: In the article be...
This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: DRUG CHANNEL IMPLICATIONS OF THE INFLATION REDUCTION ACT . For updated data on hospital-owned s...
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: DRUG CHANNEL IMPLICATIONS OF THE INFLATION REDUCTION ACT . The 2024 formularies described below s...
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: DRUG CHANNEL IMPLICATIONS OF THE INFLATION REDUCTION ACT . For more on acquisition cost reimburs...
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: DRUG CHANNEL IMPLICATIONS OF THE INFLATION REDUCTION ACT . Click here to see the original post fr...
Today’s guest post comes from Bill Dupere, SVP of Product Development & Partnerships at Mercalis. Bill discusses specialty therapy access barriers, including payer utilization management tec...
It’s finally spring in Philadelphia, home of Drug Channels. Along with sunshine and fine weather, the vernal equinox has ushered in a crop of new and noteworthy stories: What the CarelonRx/Kro...
Today’s guest post comes from Adam Stotts, SVP of Customer Success at AssistRx. Adam discusses how patients seeking to access specialty therapies can benefit from a digital intake approach. ...
Today’s guest post comes from Mark Cuban, co-founder of the Mark Cuban Cost Plus Drug Company A few weeks ago, Mark participated in the White House Roundtable on Lowering Healthcare Costs a...
I am pleased to announce our new 2024 ECONOMIC REPORT ON U.S. PHARMACIES AND PHARMACY BENEFIT MANAGERS , available for purchase and immediate download. Download a free report overview (includ...
INFORMA CONNECT’S LIFE SCIENCES PRICING & CONTRACTING USA May 21-23, 2024 | New Orleans DRUG CHANNELS READERS SAVE 10% WITH CODE 24DRCH10* Whether your daily focus is on MEDICAID, GOVERNM...
Today’s guest post comes from Josh Marsh, Vice President and General Manager of Sonexus™ Access and Patient Support at Cardinal Health. Josh discusses factors that drive manufacturers to i...
Next week, Drug Channels Institute (DCI) will release our 2024 ECONOMIC REPORT ON U.S. PHARMACIES AND PHARMACY BENEFIT MANAGERS . It’s the 15th edition of our popular and comprehensive examina...
Today’s guest post comes from Logan Melchione, VP of Patient Affordability at Paysign. Logan discusses the evolution of patient support programs. She then outlines how these programs must ev...
On March 19, 2024, Drug Channels Institute will release THE 2024 ECONOMIC REPORT ON U.S. PHARMACIES AND PHARMACY BENEFIT MANAGERS . This report—our fifteenth edition—remains the most compreh...